Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer

Study Number:S1416
IRB Number:1053708
Trial Type:Oncology - Breast
Trial Status:Open to Accrual
Date Posted:05/15/2017
Principal Investigator:Madhu Chaudhry, MD
Contact Name:Melissa Loomis
Phone:443-849-3123
Fax:(443) 849-3777
Description:

For more details on this study, please refer to the Clinicaltrials.gov website at the link below:

https://clinicaltrials.gov/ct2/show/NCT02595905?term=s1416&rank=1

IMPORTANT Visitor Policy Changes

Recent Stories
|
Video
|
In the Media